3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Papillomavirus Infections
2
Warts
1
Uterine Cervical Dysplasia
1
Infections
1
High Grade Anal Canal Intraepithelial Neoplasia
1
Condylomata Acuminata
1
Cancer Survivor
1
Interventions
Etoposide
4
Cyclophosphamide
4
Vincristine
3
Specimen Handling
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
Biopsy
3
fludarabine phosphate
2
cabozantinib
2
Whole-Body Irradiation
2
Watchful Waiting
2
Rituximab
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Gene Expression Profiling
2
Fluorouracil
2
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
prednylidene
1
pembrolizumab
1
fludarabine
1
emvododstat
1
efineptakin alfa
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
HIV Infections
×
Human Papillomavirus Recombinant Vaccine nonavalent
×
Clear all
No trials found.